ELFN2

Chr 22

extracellular leucine rich repeat and fibronectin type III domain containing 2

Also known as: LRRC62, PPP1R29

Predicted to enable protein phosphatase inhibitor activity. Predicted to be involved in synaptic membrane adhesion. Predicted to act upstream of or within chemical synaptic transmission; establishment of protein localization; and gene expression. Located in extracellular space. [provided by Alliance of Genome Resources, Jul 2025]

149
ClinVar variants
17
Pathogenic / LP
pLI score
0
Active trials
Clinical SummaryELFN2
📋
ClinVar Variants
17 Pathogenic / Likely Pathogenic· 123 VUS of 149 total submissions
Some data sources returned errors (1)

gnomad: Error: gnomAD API error: 502

Population Genetics & Constraint

Constraint data not available from gnomAD.

ClinVar Variant Classifications

149 submitted variants in ClinVar

Classification Summary

Pathogenic16
Likely Pathogenic1
VUS123
Likely Benign3
Benign2
Conflicting1
16
Pathogenic
1
Likely Pathogenic
123
VUS
3
Likely Benign
2
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
16
0
16
Likely Pathogenic
0
0
1
0
1
VUS
0
120
3
0
123
Likely Benign
0
2
0
1
3
Benign
0
2
0
0
2
Conflicting
1
Total0124201146

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ELFN2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Clinical Literature
Landmark / reviewRecent case evidence

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →